<DOC>
	<DOCNO>NCT02319395</DOCNO>
	<brief_summary>The `` Behavioural Addiction Genetics Parkinson 's Disease `` study ( BADGE-PD ) national ( France ) , multicenter , genetic association , case-control study identify genetic factor associate behavioural addiction ( Impulse Control Disorders , ICD ) relate dopamine agonist treatment Parkinson 's disease ( PD ) . Polymorphisms candidate gene suppose involved adverse effect compare 200 PD patient ICD ( n=200 ) 200 match PD patient without ICD ( n=200 ) .</brief_summary>
	<brief_title>Behavioural Addiction Genetics Parkinson 's Disease</brief_title>
	<detailed_description>Objective : To identify susceptibility gene impulse control disorder Parkinson 's Disease . Study design : Genetic association study . Primary objective : To identify susceptibility gene behavior addiction Parkinson 's Disease Secondary endpoint : - To compare clinical , neurological psychiatric feature parkinsonian patient behavior addiction compare control population . In case difference group , interaction study genetic factor - Identify psychometric profile TCI-R scale correspond `` hyperdopaminergic '' subject AC personality Patient selection : Cases : patient Parkinson 's disease ( PD ) impulse control disorder ( ICD ) define score great equal 2 3 score great equal 2 `` Evaluation Comportementale de la Maladie de Parkinson '' scale ( ECMP , Ardouin et al . 2009 ) hyperdopaminergic item . Controls : PD patient without impulse control disorder ( ICD ) define score 0 1 hyperdopaminergic item AND 2 item score 1 . Controls must treat least 300 mg Levodopa equivalent daily dose 12 month . Controls match sex , age , age onset PD . Number subject : 200 case 200 control . Clinical assessment : motor score ( UPDRS ) , neuropsychological assessment , diagnostic criterion addiction ICD ( MINI ) , self-administered psychometric questionnaire ( TCI-R ) , treatment history , ICD history . Genetic analysis : A blood sample take extraction storage DNA ( DNA bank Pitie-Salpetriere cell ) . Candidate genes* polymorphism select literature data ( receptor , transporter metabolize enzymes monoamine ) molecular signature induce L-DOPA striatum mouse model PD . Statistical analysis : A two-step analysis perform . For first step , train set ( 36 % subject ) analyze logistic regression model consider additive genetic effect . For second step , top 27 % significant genetic marker analyze use left replication set ( 64 % patient ) . Finally , pool analysis perform . Sample Size : 200 patient per group study 50 candidate marker power 83 % genotype effect 2.0 , additive genetic model , allele frequency 0.5 . * candidate gene list : 20 gene literature : DRD1 , ANKK1 , DRD2 , DRD3 , DRD4 , DAT1 , MAOA , COMT , HTR2A , HTR1B , TPH1 , TPH2 , 5HTT , GRIN2B , DBH , SCL6A2 , BDNF , OPMR1 , OPRK1 , PDYN 8 gene experimentation : FosB , Arc , Nptx2 , Ccrn4l , Car12 , C8b , Mocs1 , Mef2c</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Disruptive , Impulse Control , Conduct Disorders</mesh_term>
	<criteria>Inclusion criterion : Case Group 1 . Age upper equal 30 year 2 . Caucasian European ( 2 parent 4 grandparent bear Europe ) 3 . Parkinson 's disease accord criterion UKPDSBB 4 . With behavioral addiction define : A score great equal 2 3 score great equal 2 hyperdopaminergic follow item Ardouin 's scale ( ECMP ) : eating behavior , creativity , hobbyism , risktaking behavior , compulsive shopping , pathological gambling , hypersexuality , cyberaddiction , Punding . Onset dopamine agonist LDOPA Present inclusion visit OR past ( &lt; 6 year ) . For patient , scale Ardouin must pass time behavior trouble within 3 month disappearance . 5 . Affiliation social security 6 . Signature consent form Control Group 1 . Age upper equal 30 year 2 . Caucasian European ( 2 parent 4 grandparent bear Europe ) 3 . Parkinson 's disease accord criterion UKPDSBB 4 . Time evolution disease equal 5 year 5 . Having take evolution dopamine agonist dose least equivalent 300 mg LDOPA least 12 month . 6 . Not behavioral addiction Not current , define score 0 1 two item score 1 item addiction LDOPA . Neither pass , give authenticate semistructured interview retrospective finding score 0 1 item hyperdopaminergic Ardouin 's scale ( see ) AND two item score 1 addiction LDOPA . 7 . Affiliation social security 8 . Signature consent form Exclusion criterion : Case Group 1 . No Parkinson 's disease atypical parkinsonian syndrome 2 . Taking neuroleptic except clozapine patient AC 3 . Behavioral Addiction start BEFORE take antiparkinsonian treatment Control Group 1 . No Parkinson 's disease atypical parkinsonian syndrome 2 . Taking neuroleptic included clozapine control patient 3 . Behavioral Addiction start BEFORE take antiparkinsonian treatment 4 . Patient guardianship , deprive liberty judicial decision</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Parkinson 's Disease</keyword>
	<keyword>Behaviour addiction</keyword>
	<keyword>Dopamine agonist</keyword>
	<keyword>Genetic .</keyword>
</DOC>